Literature DB >> 18827382

New organoselenium compounds active against pathogenic bacteria, fungi and viruses.

Magdalena Pietka-Ottlik1, Halina Wójtowicz-Młochowska, Katarzyna Kołodziejczyk, Egbert Piasecki, Jacek Młochowski.   

Abstract

Different N-substituted benzisoselenazol-3(2H)-ones, analogues of ebselen were designed as new antiviral and antimicrobial agents. We report their synthesis, chemical properties as well as study on biological activity against broad spectrum of pathogenic microorganisms (Staphylococcus aureus, Staphylococcus simulans, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Candida albicans, Aspergillus niger) and viruses (herpes simplex virus type 1 (HSV-1), encephalomyocarditis virus (EMCV), vesicular stomatitis virus (VSV)), in vitro. Most of them exhibited high activity against viruses (HSV-1, EMCV) and gram-positive bacteria strains (S. aureus, S. simulans), while their activity against gram-negative bacteria strains (E. coli, P. aeruginosa, K. pneumoniae) was substantially lower. Some of tested compounds were active against yeast C. albicans and filamentous fungus A. niger.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18827382     DOI: 10.1248/cpb.56.1423

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  12 in total

1.  High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.

Authors:  Matthew J Saunders; Steven W Graves; Larry A Sklar; Tudor I Oprea; Bruce S Edwards
Journal:  Assay Drug Dev Technol       Date:  2010-02       Impact factor: 1.738

2.  Thermal and Photoinduced Copper-Promoted C-Se Bond Formation: Synthesis of 2-Alkyl-1,2-benzisoselenazol-3(2H)-ones and Evaluation against Mycobacterium tuberculosis.

Authors:  Sandeep Thanna; Christopher M Goins; Susan E Knudson; Richard A Slayden; Donald R Ronning; Steven J Sucheck
Journal:  J Org Chem       Date:  2017-03-20       Impact factor: 4.354

3.  Carboxyl-ebselen-based layer-by-layer films as potential antithrombotic and antimicrobial coatings.

Authors:  Wenyi Cai; Jianfeng Wu; Chuanwu Xi; Arthur J Ashe; Mark E Meyerhoff
Journal:  Biomaterials       Date:  2011-07-26       Impact factor: 12.479

4.  Selenium nanoparticles inhibit Staphylococcus aureus growth.

Authors:  Phong A Tran; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2011-07-29

5.  Inhibition of various gram-positive and gram-negative bacteria growth on selenium nanoparticle coated paper towels.

Authors:  Qi Wang; Philip Larese-Casanova; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2015-04-13

6.  Reaction of bis[(2-chlorocarbonyl)phenyl] Diselenide with Phenols, Aminophenols, and Other Amines towards Diphenyl Diselenides with Antimicrobial and Antiviral Properties.

Authors:  Mirosław Giurg; Anna Gołąb; Jakub Suchodolski; Rafał Kaleta; Anna Krasowska; Egbert Piasecki; Magdalena Piętka-Ottlik
Journal:  Molecules       Date:  2017-06-12       Impact factor: 4.411

7.  Selenazolinium Salts as "Small Molecule Catalysts" with High Potency against ESKAPE Bacterial Pathogens.

Authors:  Karolina Witek; Muhammad Jawad Nasim; Markus Bischoff; Rosmarie Gaupp; Pavel Arsenyan; Jelena Vasiljeva; Małgorzata Anna Marć; Agnieszka Olejarz; Gniewomir Latacz; Katarzyna Kieć-Kononowicz; Jadwiga Handzlik; Claus Jacob
Journal:  Molecules       Date:  2017-12-08       Impact factor: 4.411

8.  Crucial role of selenium in the virucidal activity of benzisoselenazol-3(2H)-ones and related diselenides.

Authors:  Magdalena Pietka-Ottlik; Piotr Potaczek; Egbert Piasecki; Jacek Mlochowski
Journal:  Molecules       Date:  2010-11-12       Impact factor: 4.411

9.  Cytotoxicity of selenium nanoparticles in rat dermal fibroblasts.

Authors:  Joseph F Ramos; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2012-07-23

Review 10.  Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System.

Authors:  Holly C May; Jieh-Juen Yu; M N Guentzel; James P Chambers; Andrew P Cap; Bernard P Arulanandam
Journal:  Front Microbiol       Date:  2018-03-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.